$XHR
Xenia Hotels & Resorts, Inc.

2021 Q4 Form 10-Q Financial Statement

#000161600021000128 Filed on November 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $203.6M $172.8M $63.95M
YoY Change 169.13% 170.17% -76.22%
Cost Of Revenue $88.10M $122.8M $67.39M
YoY Change 82.02% 82.29% -64.0%
Gross Profit $115.5M $49.94M -$3.439M
YoY Change 323.0% -1552.02% -104.21%
Gross Profit Margin 56.73% 28.9% -5.38%
Selling, General & Admin $70.03M $64.39M $42.20M
YoY Change 78.18% 52.59% -52.48%
% of Gross Profit 60.64% 128.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $31.11M $32.08M $37.20M
YoY Change -10.6% -13.77% -4.86%
% of Gross Profit 26.94% 64.24%
Operating Expenses $101.1M $96.47M $79.50M
YoY Change 36.26% 21.34% -37.84%
Operating Profit $14.38M -$1.502M -$70.02M
YoY Change -130.65% -97.85% -445.52%
Interest Expense -$21.49M $21.36M $17.01M
YoY Change 16.77% 25.59% 38.34%
% of Operating Profit -149.45%
Other Income/Expense, Net $206.0K $186.0K $26.97M
YoY Change -151.5% -99.31% 10392.22%
Pretax Income -$22.84M -$22.67M -$60.06M
YoY Change -186.83% -62.25% -829.91%
Income Tax $341.0K $43.00K -$6.400M
% Of Pretax Income
Net Earnings -$22.94M -$22.19M -$52.34M
YoY Change -194.47% -57.6% -607.46%
Net Earnings / Revenue -11.27% -12.84% -81.85%
Basic Earnings Per Share -$0.20 -$0.46
Diluted Earnings Per Share -$201.5K -$0.20 -$0.46
COMMON SHARES
Basic Shares Outstanding 114.2M shares 113.8M shares 113.7M shares
Diluted Shares Outstanding 113.8M shares 113.7M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $517.4M $517.5M $321.1M
YoY Change 32.73% 61.15% 175.62%
Cash & Equivalents $517.4M $517.5M $321.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $28.53M $23.83M $9.100M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $545.9M $541.3M $330.2M
YoY Change 36.89% 63.93% 106.38%
LONG-TERM ASSETS
Property, Plant & Equipment $2.419B $2.489B $2.799B
YoY Change -6.64% -11.1% -1.85%
Goodwill $4.850M $4.850M $4.850M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $71.48M $42.20M $161.5M
YoY Change 83.27% -73.87% 91.12%
Total Long-Term Assets $2.541B $2.576B $3.010B
YoY Change -5.2% -14.43% 0.37%
TOTAL ASSETS
Total Short-Term Assets $545.9M $541.3M $330.2M
Total Long-Term Assets $2.541B $2.576B $3.010B
Total Assets $3.087B $3.117B $3.340B
YoY Change 0.25% -6.69% 5.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $84.05M $89.63M $73.60M
YoY Change 34.05% 21.79% -32.04%
Accrued Expenses $20.88M $23.29M $26.60M
YoY Change -13.01% -12.46% -3.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $104.9M $112.9M $100.4M
YoY Change 20.75% 12.47% -40.1%
LONG-TERM LIABILITIES
Long-Term Debt $1.494B $1.494B $1.584B
YoY Change 8.71% -5.63% 37.88%
Other Long-Term Liabilities $50.08M $52.94M $120.0M
YoY Change -2.58% -55.88% 111.64%
Total Long-Term Liabilities $1.544B $1.547B $1.704B
YoY Change 8.3% -9.17% 41.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $104.9M $112.9M $100.4M
Total Long-Term Liabilities $1.544B $1.547B $1.704B
Total Liabilities $1.649B $1.660B $1.804B
YoY Change 9.02% -7.98% 31.41%
SHAREHOLDERS EQUITY
Retained Earnings -$656.5M -$633.6M -$537.3M
YoY Change 27.96% 17.91% 77.34%
Common Stock $1.143M $1.142M $1.138M
YoY Change 0.44% 0.35% 0.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.431B $1.452B $1.526B
YoY Change
Total Liabilities & Shareholders Equity $3.087B $3.117B $3.340B
YoY Change 0.25% -6.69% 5.74%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$22.94M -$22.19M -$52.34M
YoY Change -194.47% -57.6% -607.46%
Depreciation, Depletion And Amortization $31.11M $32.08M $37.20M
YoY Change -10.6% -13.77% -4.86%
Cash From Operating Activities $11.41M $24.53M $4.500M
YoY Change -133.56% 445.13% -93.77%
INVESTING ACTIVITIES
Capital Expenditures -$12.67M -$7.300M -$17.60M
YoY Change 15.17% -58.52% -32.82%
Acquisitions
YoY Change
Other Investing Activities $5.085M $645.0K $2.900M
YoY Change -98.41% -77.76%
Cash From Investing Activities -$7.584M -$6.655M -$14.70M
YoY Change -102.45% -54.73% -43.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.559M -821.0K 10.80M
YoY Change -99.27% -107.6% -133.23%
NET CHANGE
Cash From Operating Activities 11.41M 24.53M 4.500M
Cash From Investing Activities -7.584M -6.655M -14.70M
Cash From Financing Activities -1.559M -821.0K 10.80M
Net Change In Cash 2.267M 17.05M 600.0K
YoY Change -96.31% 2742.5% -95.56%
FREE CASH FLOW
Cash From Operating Activities $11.41M $24.53M $4.500M
Capital Expenditures -$12.67M -$7.300M -$17.60M
Free Cash Flow $24.08M $31.83M $22.10M
YoY Change -204.69% 44.03% -77.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Central Index Key
EntityCentralIndexKey
0001616000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36594
dei Entity Registrant Name
EntityRegistrantName
Xenia Hotels & Resorts, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0141677
dei Entity Address Address Line1
EntityAddressAddressLine1
200 S. Orange Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2700
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
dei City Area Code
CityAreaCode
407
dei Local Phone Number
LocalPhoneNumber
246-8100
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
XHR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114209134 shares
CY2021Q3 us-gaap Land
Land
446510000 USD
CY2020Q4 us-gaap Land
Land
446855000 USD
CY2021Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2925556000 USD
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2949114000 USD
CY2021Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3372066000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3395969000 USD
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
905463000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
827501000 USD
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2466603000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
2568468000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
517464000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
389823000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
34500000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
38963000 USD
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
23833000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
8966000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3939000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3183000 USD
CY2021Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5699000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
6456000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
61119000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
66927000 USD
CY2021Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
7695000 USD
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q3 us-gaap Assets
Assets
3116913000 USD
CY2020Q4 us-gaap Assets
Assets
3079603000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1494287000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1374480000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
89634000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
62676000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
73400000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
75584000 USD
CY2021Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
2829000 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
0 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1660150000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1512740000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114209134 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114209134 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113755513 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113755513 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1142000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1138000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2090329000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2080364000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6243000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14425000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633584000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-513002000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1451644000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1554075000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
5119000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
12788000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1456763000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1566863000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3116913000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3079603000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172784000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63954000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
412610000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294129000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
122849000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
67393000 USD
us-gaap Cost Of Revenue
CostOfRevenue
305836000 USD
us-gaap Cost Of Revenue
CostOfRevenue
281181000 USD
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32076000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37307000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
98281000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
111660000 USD
CY2021Q3 xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
9731000 USD
CY2020Q3 xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
13028000 USD
xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
31268000 USD
xhr Real Estate Taxes Personal Property Taxes And Insurance
RealEstateTaxesPersonalPropertyTaxesAndInsurance
39800000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
405000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
478000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1187000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1604000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7466000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6676000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22484000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24656000 USD
CY2021Q3 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 USD
CY2020Q3 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 USD
us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
1116000 USD
us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 USD
CY2021Q3 xhr Acquisition Terminated Transaction And Pre Opening Expenses
AcquisitionTerminatedTransactionAndPreOpeningExpenses
0 USD
CY2020Q3 xhr Acquisition Terminated Transaction And Pre Opening Expenses
AcquisitionTerminatedTransactionAndPreOpeningExpenses
146000 USD
xhr Acquisition Terminated Transaction And Pre Opening Expenses
AcquisitionTerminatedTransactionAndPreOpeningExpenses
0 USD
xhr Acquisition Terminated Transaction And Pre Opening Expenses
AcquisitionTerminatedTransactionAndPreOpeningExpenses
994000 USD
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1759000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8942000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14072000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
29044000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
174286000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
133970000 USD
us-gaap Costs And Expenses
CostsAndExpenses
472012000 USD
us-gaap Costs And Expenses
CostsAndExpenses
488939000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1502000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-70016000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-59402000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-194810000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
186000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26965000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2503000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29335000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
21358000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
17006000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-209076000 USD
us-gaap Interest Expense
InterestExpense
59799000 USD
us-gaap Interest Expense
InterestExpense
43601000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1356000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22674000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60057000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-123060000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6448000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
377000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16849000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-22717000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-53609000 USD
us-gaap Profit Loss
ProfitLoss
-123437000 USD
us-gaap Profit Loss
ProfitLoss
-192227000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-524000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1265000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2855000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4619000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22193000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-52344000 USD
us-gaap Net Income Loss
NetIncomeLoss
-120582000 USD
us-gaap Net Income Loss
NetIncomeLoss
-187608000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113809212 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113809212 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113730716 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113730716 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113798761 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113798761 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113407217 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113407217 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-22717000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-53609000 USD
us-gaap Profit Loss
ProfitLoss
-123437000 USD
us-gaap Profit Loss
ProfitLoss
-192227000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-163000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
264000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2389000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-18535000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1598000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-2840000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5999000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5511000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21282000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-50505000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-115049000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-205251000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-490000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1191000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2649000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-5015000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20792000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49314000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-112400000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-200236000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1475094000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-22717000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2951000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-163000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1598000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1456763000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1584224000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-53609000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2496000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
264000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-2840000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1536215000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1566863000 USD
us-gaap Profit Loss
ProfitLoss
-123437000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9355000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
318000 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-4088000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2389000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5999000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1456763000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1775158000 USD
us-gaap Profit Loss
ProfitLoss
-192227000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2264000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.275
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
31620000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9380000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
565000 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-8623000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-18535000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5511000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1536215000 USD
us-gaap Profit Loss
ProfitLoss
-123437000 USD
us-gaap Profit Loss
ProfitLoss
-192227000 USD
us-gaap Depreciation
Depreciation
97478000 USD
us-gaap Depreciation
Depreciation
109732000 USD
xhr Noncash Ground Rent And Amortization Of Other Intangibles
NoncashGroundRentAndAmortizationOfOtherIntangibles
803000 USD
xhr Noncash Ground Rent And Amortization Of Other Intangibles
NoncashGroundRentAndAmortizationOfOtherIntangibles
1988000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4615000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2205000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1356000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
13072000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
29044000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8813000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8574000 USD
xhr Interest Expense Noncash
InterestExpenseNoncash
0 USD
xhr Interest Expense Noncash
InterestExpenseNoncash
1746000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
508000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
15683000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-26775000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1343000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
15474000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28742000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12958000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12251000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3624000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29353000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43711000 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
19150000 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
58157000 USD
xhr Proceeds From Performance Guaranty Payments
ProceedsFromPerformanceGuarantyPayments
2524000 USD
xhr Proceeds From Performance Guaranty Payments
ProceedsFromPerformanceGuarantyPayments
2863000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16626000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55294000 USD
xhr Repayments Of Secured Debt Payoffs
RepaymentsOfSecuredDebtPayoffs
56750000 USD
xhr Repayments Of Secured Debt Payoffs
RepaymentsOfSecuredDebtPayoffs
0 USD
xhr Repayments Of Secured Debt Principal Payments
RepaymentsOfSecuredDebtPrincipalPayments
4888000 USD
xhr Repayments Of Secured Debt Principal Payments
RepaymentsOfSecuredDebtPrincipalPayments
1533000 USD
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
150000000 USD
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
87600000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
340000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
163093000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
193800000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
500000000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
300000000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
10233000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
10828000 USD
xhr Payments For Redemption Of Partnership Capital Units
PaymentsForRedemptionOfPartnershipCapitalUnits
4088000 USD
xhr Payments For Redemption Of Partnership Capital Units
PaymentsForRedemptionOfPartnershipCapitalUnits
8623000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2264000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
443000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
783000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
54000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
63162000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
110451000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
271407000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
123178000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
172402000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
428786000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
194946000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551964000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367348000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
517464000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
321051000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
34500000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
46297000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551964000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367348000 USD
us-gaap Interest Paid Net
InterestPaidNet
55427000 USD
us-gaap Interest Paid Net
InterestPaidNet
35651000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
163000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3300000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
206000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2506000 USD
xhr Deferred Interest Added To Mortgage Principal Balance
DeferredInterestAddedToMortgagePrincipalBalance
0 USD
xhr Deferred Interest Added To Mortgage Principal Balance
DeferredInterestAddedToMortgagePrincipalBalance
1746000 USD
us-gaap Nature Of Operations
NatureOfOperations
Organization<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia Hotels &amp; Resorts, Inc. (the "Company" or "Xenia") is a Maryland corporation that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 U.S. lodging markets as well as key leisure destinations in the United States. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company's assets are held by, and all the operations are conducted through, XHR LP (the "Operating Partnership"). XHR GP, Inc. is the sole general partner of XHR LP and is wholly-owned by the Company. As of September 30, 2021, the Company collectively owned 97.7% of the common limited partnership units issued by the Operating Partnership ("Operating Partnership Units"). The remaining 2.3% of the Operating Partnership Units are owned by the other limited partners comprised of certain of our current executive officers and members of our Board of Directors and includes vested and unvested long-term incentive plan ("LTIP") partnership units. LTIP partnership units may or may not vest based on the passage of time and whether certain market-based performance objectives are met. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xenia operates as a real estate investment trust ("REIT"). To qualify as a REIT the Company cannot operate or manage its hotels. Therefore, the Operating Partnership and its subsidiaries lease the hotel properties to XHR Holding, Inc. and its subsidiaries (collectively with its subsidiaries, "XHR Holding"), the Company's taxable REIT subsidiary ("TRS"), which engages third-party eligible independent contractors to manage the hotels. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and 2020, the Company owned 35 and 39 lodging properties, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, confirmed cases of novel coronavirus and related respiratory disease ("COVID-19") started appearing in the United States ("U.S."). By March 2020, COVID-19 was deemed a global pandemic by the World Health Organization. This led federal, state and local governments in the United States to impose measures intended to control its spread, including restrictions on freedom of movement and business operations such as travel bans, border closings, business closures, school closures, quarantines, shelter-in-place orders and social distancing requirements, and also to implement phased, multi-step policies governing re-opening regions of the country. The effects of the COVID-19 pandemic on the hotel industry have been significant and unprecedented with global demand for lodging drastically reduced and occupancy levels reaching historic lows in 2020. As a result of the COVID-19 pandemic, the majority of the Company's hotels and resorts temporarily suspended operations for certain periods of time during 2020. All of the Company's lodging properties had resumed operations as of May 2021.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leisure demand gradually improved during the second half of 2020, a trend that accelerated during the first seven months of 2021 and the Company also began to see increasing levels of demand for both business transient and group business during the second quarter and into July 2021. In August and September 2021, however, the Company began to experience a softening in demand due to the impact of the Delta variant, a seasonal decline in leisure demand and a shift in the timing of the Jewish holidays. Additionally, many companies delayed their office re-openings and return to work timelines and we began to experience group business cancellations for meetings being held in 2021 and the first quarter of 2022. As of September 30, 2021, COVID-19 case counts, positivity ratios and hospitalizations had begun to decline in many parts of the U.S. Despite this relative improvement, there remains significant uncertainty regarding the pace of recovery and the length of time it will take for business travel and larger group meetings to return to pre-pandemic levels. The Company may be impacted by, among other things, the distribution and acceptance of COVID-19 vaccines, breakthrough cases, and resurgences of COVID-19, including the Delta variant or other variants, which continue to result in indoor mask mandates and other restrictions. As the recovery continues, we expect that the pace will vary from market to market and may be uneven in nature.</span></div>
CY2021Q3 xhr Number Of Top Lodging Markets For Investing
NumberOfTopLodgingMarketsForInvesting
25 market
CY2021Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
35 property
CY2020Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
39 property
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationsCertain prior year amounts in these condensed consolidated financial statements have been reclassified to conform to the presentation as of and for the three and nine months ended September 30, 2021.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and revenues and expenses. These estimates are prepared using management's best judgment, after considering past, current and expected future economic conditions. Actual results could differ from these estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Risks and Uncertainties</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the COVID-19 pan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demic, the majority of the Company's hotels and resorts temporarily suspended operations for certain periods of time during 2020. All of the Company's hotels had resumed operations by May 2021. The Company's portfolio consists of luxury and upper upscale hotels and resorts, which generally offer restaurant and bar venues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, large meeting facilities and event space, and amenities, including spas and golf courses, some of which may have limited operations or may not be able to operate during the recovery in order to comply with implemented safety measures, ongoing or reimplemented restrictions and to accommodate reduced levels of demand. The Company continues to monitor the evolving situation and guidance from federal, state and local governmental and public health authorities and additional actions may be taken or required based on their recommendations and regulations in place. Under these circumstances, there may be developments that require further adjustments to operations. </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict with certainty when business levels will return to normalized levels after the effects of the pandemic subside or whether hotels that have recommenced operations will be forced to suspend operations or impose additional restrictions due to resurgences of COVID-19 cases, including the Delta variant or other variants. The Company expects that recovery in the lodging industry, particularly with respect to business transient and group business, will continue to lag behind the recovery of other industries and factors such as public health (including a significant increase in new variant strains of COVID-19 cases), availability and effectiveness of COVID-19 vaccines and therapeutics, the level of acceptance of the vaccine by the general population, waning immunity and the economic and geopolitical environments may impact the timing, extent and pace of such recovery. Additionally, the effects of the pandemic could materially and adversely affect the Company's ability to consummate acquisitions and dispositions of hotel properties in the near term as well as cause scale backs or delays in planned renovations and other projects. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict with certainty the full extent and duration of the effects of the COVID-19 pandemic on its business, operating margins, results of operations, cash flows, financial condition, the market price of its common stock, its ability to make distributions to its shareholders, its access to equity and credit markets or its ability to service its indebtedness. Further, we continue to monitor and evaluate the challenges associated with the evolving workforce landscape, particularly related to achieving the appropriate balance between hotel staffing levels and demand as well as ongoing supply chain issues which may impact the hotels' ability to source operating supplies and other materials.</span></div>
CY2020Q4 us-gaap Goodwill
Goodwill
4900000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
4900000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20100000 USD
CY2021Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
27600000 USD
CY2021Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
7800000 USD
CY2020Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
7200000 USD
CY2021Q3 us-gaap Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements
AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements
5000000 USD
CY2020Q4 us-gaap Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements
AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements
3200000 USD
CY2020Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
21000000 USD
CY2021Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
6200000 USD
CY2020Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
5100000 USD
CY2021Q3 xhr Number Of Mortgage Loans Amended
NumberOfMortgageLoansAmended
2 loan
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172784000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
412610000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63954000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294129000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
21355000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15892000 USD
CY2021Q3 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0518
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1494287000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1374480000 USD
CY2021Q3 xhr Debt Instrument Carrying Amount And Line Of Credit
DebtInstrumentCarryingAmountAndLineOfCredit
1516000000 USD
CY2020Q4 xhr Debt Instrument Carrying Amount And Line Of Credit
DebtInstrumentCarryingAmountAndLineOfCredit
1390000000 USD
CY2021Q3 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0518
CY2020Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0478
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1015000 USD
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYearWeightedAverageInterestRate
0.0436
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4653000 USD
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal In Year One Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearOneWeightedAverageInterestRate
0.0438
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5537000 USD
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal In Year Two Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoWeightedAverageInterestRate
0.0439
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
280160000 USD
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal In Year Three Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeWeightedAverageInterestRate
0.0388
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
568512000 USD
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal In Year Four Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourWeightedAverageInterestRate
0.0626
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
655765000 USD
CY2021Q3 xhr Long Term Debt Maturities Repayments Of Principal After Year Four Weighted Average Interest Rate
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFourWeightedAverageInterestRate
0.0481
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1515642000 USD
CY2021Q3 xhr Long Term Debt Gross Weighted Average Interest Rate
LongTermDebtGrossWeightedAverageInterestRate
0.0518
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0293
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
21355000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1494287000 USD
CY2021Q3 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0518
xhr Number Of Mortgage Loans Repaid
NumberOfMortgageLoansRepaid
1 loan
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
1400000 USD
xhr Derivative Number Of Instruments Terminated
DerivativeNumberOfInstrumentsTerminated
4 derivative_instrument
xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
-2800000 USD
CY2021Q2 xhr Number Of Mortgage Loans Repaid
NumberOfMortgageLoansRepaid
1 loan
CY2021Q2 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
150000000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-163000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
264000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2389000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-18535000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1598000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-2840000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5999000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5511000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
21358000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
17006000 USD
us-gaap Interest Expense
InterestExpense
59799000 USD
us-gaap Interest Expense
InterestExpense
43601000 USD
CY2021Q3 xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
0 USD
CY2020Q3 xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
0 USD
xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
-2779000 USD
xhr Gain Loss On Termination Of Derivatives
GainLossOnTerminationOfDerivatives
0 USD
CY2021Q3 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
-6100000 USD
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
CY2021Q3 us-gaap Goodwill Gross
GoodwillGross
34352000 USD
CY2021Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
29502000 USD
CY2020Q4 us-gaap Goodwill Gross
GoodwillGross
34352000 USD
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
29502000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
4850000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4850000 USD
CY2020Q1 xhr Goodwill Impairment Analysis Number Of Hotels
GoodwillImpairmentAnalysisNumberOfHotels
3 property
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20100000 USD
CY2021Q3 xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.0300
xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.0300
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 USD
xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.1937
CY2020Q3 xhr Effective Income Tax Rate Reconciliation At Federal And State Combined Effective Rate
EffectiveIncomeTaxRateReconciliationAtFederalAndStateCombinedEffectiveRate
0.1937
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16800000 USD
xhr Common Stock Maximum Authorized Pursuant To At The Market Agreements Value
CommonStockMaximumAuthorizedPursuantToAtTheMarketAgreementsValue
200000000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
xhr Common Stock Maximum Authorized Pursuant To At The Market Agreements Value
CommonStockMaximumAuthorizedPursuantToAtTheMarketAgreementsValue
200000000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
165516 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
13.68
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2300000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.275
CY2020Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2020-03-31
us-gaap Partners Capital Account Units Redeemed
PartnersCapitalAccountUnitsRedeemed
215344 shares
CY2020Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2020-04-15
xhr Payments For Redemption Of Partnership Capital Units
PaymentsForRedemptionOfPartnershipCapitalUnits
4100000 USD
us-gaap Partners Capital Account Units Redeemed
PartnersCapitalAccountUnitsRedeemed
457017 shares
xhr Payments For Redemption Of Partnership Capital Units
PaymentsForRedemptionOfPartnershipCapitalUnits
8600000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22193000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-52344000 USD
us-gaap Net Income Loss
NetIncomeLoss
-120582000 USD
us-gaap Net Income Loss
NetIncomeLoss
-187608000 USD
CY2021Q3 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
0 USD
CY2020Q3 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
0 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
0 USD
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
150000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22193000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22193000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-52344000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-52344000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-120582000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-120582000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-187758000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-187758000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113809212 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113730716 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113798761 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113407217 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113407217 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113809212 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113730716 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113798761 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113407217 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
580479 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
563820 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
263383 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
260270 shares
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
14300000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1882197 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
940662 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
195617 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
4291 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2622951 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.56
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0031
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
1900000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P23Y
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0579
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21954000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
23286000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1659000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
2198000 USD
us-gaap Lease Cost
LeaseCost
3857000 USD
xhr Operating Lease Including Available Extension Options Weighted Average Remaining Lease Term
OperatingLeaseIncludingAvailableExtensionOptionsWeightedAverageRemainingLeaseTerm
P59Y
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
565000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2273000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2287000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2302000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2317000 USD
CY2021Q3 xhr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
34926000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
44670000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21384000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
23286000 USD

Files In Submission

Name View Source Status
0001616000-21-000128-index-headers.html Edgar Link pending
0001616000-21-000128-index.html Edgar Link pending
0001616000-21-000128.txt Edgar Link pending
0001616000-21-000128-xbrl.zip Edgar Link pending
exhibit311_2021q3x10q.htm Edgar Link pending
exhibit312_2021q3x10q.htm Edgar Link pending
exhibit321_2021q3x10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xhr-20210930.htm Edgar Link pending
xhr-20210930.xsd Edgar Link pending
xhr-20210930_cal.xml Edgar Link unprocessable
xhr-20210930_def.xml Edgar Link unprocessable
xhr-20210930_htm.xml Edgar Link completed
xhr-20210930_lab.xml Edgar Link unprocessable
xhr-20210930_pre.xml Edgar Link unprocessable